HLV Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 28, 2025, 8:39 pm

Quick Insight

HLV Ltd, operating in the Hotels, Resorts & Restaurants sector, currently exhibits a price of 11.6 with a market capitalization of 752 Cr. Despite a relatively high P/E ratio of 37.2, the company's ROE and ROCE stand at 5.55% and 5.59%, respectively, indicating moderate returns on equity and capital employed. However, with an OPM at -4.20% and a negative ICR of -33.49x, the company faces operational and liquidity challenges. Furthermore, its CCC at -2,102 days raises concerns about efficient cash flow management. The low P/BV ratio of 0.44x suggests the stock may be undervalued, but the high level of borrowings at ₹41 Cr. warrants caution. In conclusion, HLV Ltd appears to be struggling with profitability and liquidity issues despite potential undervaluation, highlighting the need for a comprehensive turnaround strategy to enhance financial health and investor confidence.

Competitors of HLV Ltd

All Competitor Stocks of HLV Ltd

Quarterly Result

Last Updated: August 20, 2025, 9:35 am

Below is a detailed analysis of the quarterly data for HLV Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 40.74 Cr.. The value appears to be declining and may need further review. It has decreased from 59.26 Cr. (Mar 2025) to 40.74 Cr., marking a decrease of 18.52 Cr..
• For Expenses, as of Jun 2025, the value is 42.45 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 46.38 Cr. (Mar 2025) to 42.45 Cr., marking a decrease of 3.93 Cr..
• For Operating Profit, as of Jun 2025, the value is -1.71 Cr.. The value appears to be declining and may need further review. It has decreased from 12.88 Cr. (Mar 2025) to -1.71 Cr., marking a decrease of 14.59 Cr..
• For OPM %, as of Jun 2025, the value is -4.20%. The value appears to be declining and may need further review. It has decreased from 21.73% (Mar 2025) to -4.20%, marking a decrease of 25.93%.
• For Other Income, as of Jun 2025, the value is 3.23 Cr.. The value appears strong and on an upward trend. It has increased from 2.69 Cr. (Mar 2025) to 3.23 Cr., marking an increase of 0.54 Cr..
• For Interest, as of Jun 2025, the value is 0.61 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.58 Cr. (Mar 2025) to 0.61 Cr., marking an increase of 0.03 Cr..
• For Depreciation, as of Jun 2025, the value is 4.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 4.25 Cr. (Mar 2025) to 4.38 Cr., marking an increase of 0.13 Cr..
• For Profit before tax, as of Jun 2025, the value is -3.47 Cr.. The value appears to be declining and may need further review. It has decreased from 10.74 Cr. (Mar 2025) to -3.47 Cr., marking a decrease of 14.21 Cr..
• For Tax %, as of Jun 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00%.
• For Net Profit, as of Jun 2025, the value is -3.47 Cr.. The value appears to be declining and may need further review. It has decreased from 10.74 Cr. (Mar 2025) to -3.47 Cr., marking a decrease of 14.21 Cr..
• For EPS in Rs, as of Jun 2025, the value is -0.05. The value appears to be declining and may need further review. It has decreased from 0.16 (Mar 2025) to -0.05, marking a decrease of 0.21.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 3:41 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: June 16, 2025, 12:00 pm

Below is a detailed analysis of the balance sheet data for HLV Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 132.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 132.00 Cr..
• For Reserves, as of Mar 2025, the value is 336.00 Cr.. The value appears strong and on an upward trend. It has increased from 312.00 Cr. (Mar 2024) to 336.00 Cr., marking an increase of 24.00 Cr..
• For Borrowings, as of Mar 2025, the value is 41.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 33.00 Cr. (Mar 2024) to 41.00 Cr., marking an increase of 8.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 123.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 104.00 Cr. (Mar 2024) to 123.00 Cr., marking an increase of 19.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 632.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 580.00 Cr. (Mar 2024) to 632.00 Cr., marking an increase of 52.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 318.00 Cr.. The value appears strong and on an upward trend. It has increased from 309.00 Cr. (Mar 2024) to 318.00 Cr., marking an increase of 9.00 Cr..
• For CWIP, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 9.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 304.00 Cr.. The value appears strong and on an upward trend. It has increased from 269.00 Cr. (Mar 2024) to 304.00 Cr., marking an increase of 35.00 Cr..
• For Total Assets, as of Mar 2025, the value is 632.00 Cr.. The value appears strong and on an upward trend. It has increased from 580.00 Cr. (Mar 2024) to 632.00 Cr., marking an increase of 52.00 Cr..

Notably, the Reserves (336.00 Cr.) exceed the Borrowings (41.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Key Financial Ratios

After reviewing the key financial ratios for HLV Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 20, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 20, the value is 3.07. This value is below the healthy minimum of 5. It has increased from -1.89 (Mar 19) to 3.07, marking an increase of 4.96.
• For Diluted EPS (Rs.), as of Mar 20, the value is 3.07. This value is below the healthy minimum of 5. It has increased from -1.89 (Mar 19) to 3.07, marking an increase of 4.96.
• For Cash EPS (Rs.), as of Mar 20, the value is 3.26. This value is within the healthy range. It has increased from -0.44 (Mar 19) to 3.26, marking an increase of 3.70.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 7.25. It has increased from 4.21 (Mar 19) to 7.25, marking an increase of 3.04.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 7.25. It has increased from 4.21 (Mar 19) to 7.25, marking an increase of 3.04.
• For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 2.31. It has decreased from 2.45 (Mar 19) to 2.31, marking a decrease of 0.14.
• For PBDIT / Share (Rs.), as of Mar 20, the value is -0.48. This value is below the healthy minimum of 2. It has decreased from 0.02 (Mar 19) to -0.48, marking a decrease of 0.50.
• For PBIT / Share (Rs.), as of Mar 20, the value is -0.67. This value is below the healthy minimum of 0. It has decreased from -0.12 (Mar 19) to -0.67, marking a decrease of 0.55.
• For PBT / Share (Rs.), as of Mar 20, the value is -0.32. This value is below the healthy minimum of 0. It has increased from -0.59 (Mar 19) to -0.32, marking an increase of 0.27.
• For Net Profit / Share (Rs.), as of Mar 20, the value is 3.07. This value is within the healthy range. It has increased from -0.59 (Mar 19) to 3.07, marking an increase of 3.66.
• For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 3.07. This value is within the healthy range. It has increased from -1.89 (Mar 19) to 3.07, marking an increase of 4.96.
• For PBDIT Margin (%), as of Mar 20, the value is -20.90. This value is below the healthy minimum of 10. It has decreased from 1.18 (Mar 19) to -20.90, marking a decrease of 22.08.
• For PBIT Margin (%), as of Mar 20, the value is -29.09. This value is below the healthy minimum of 10. It has decreased from -5.01 (Mar 19) to -29.09, marking a decrease of 24.08.
• For PBT Margin (%), as of Mar 20, the value is -13.86. This value is below the healthy minimum of 10. It has increased from -24.48 (Mar 19) to -13.86, marking an increase of 10.62.
• For Net Profit Margin (%), as of Mar 20, the value is 132.97. This value exceeds the healthy maximum of 10. It has increased from -24.48 (Mar 19) to 132.97, marking an increase of 157.45.
• For NP After MI And SOA Margin (%), as of Mar 20, the value is 132.97. This value exceeds the healthy maximum of 20. It has increased from -77.05 (Mar 19) to 132.97, marking an increase of 210.02.
• For Return on Networth / Equity (%), as of Mar 20, the value is 42.35. This value is within the healthy range. It has increased from -44.79 (Mar 19) to 42.35, marking an increase of 87.14.
• For Return on Capital Employeed (%), as of Mar 20, the value is -8.54. This value is below the healthy minimum of 10. It has decreased from -0.77 (Mar 19) to -8.54, marking a decrease of 7.77.
• For Return On Assets (%), as of Mar 20, the value is 29.36. This value is within the healthy range. It has increased from -2.83 (Mar 19) to 29.36, marking an increase of 32.19.
• For Long Term Debt / Equity (X), as of Mar 20, the value is 0.01. This value is below the healthy minimum of 0.2. It has decreased from 2.68 (Mar 19) to 0.01, marking a decrease of 2.67.
• For Total Debt / Equity (X), as of Mar 20, the value is 0.07. This value is within the healthy range. It has decreased from 2.89 (Mar 19) to 0.07, marking a decrease of 2.82.
• For Asset Turnover Ratio (%), as of Mar 20, the value is 0.06. It has increased from 0.03 (Mar 19) to 0.06, marking an increase of 0.03.
• For Current Ratio (X), as of Mar 20, the value is 1.58. This value is within the healthy range. It has increased from 1.18 (Mar 19) to 1.58, marking an increase of 0.40.
• For Quick Ratio (X), as of Mar 20, the value is 1.54. This value is within the healthy range. It has increased from 1.18 (Mar 19) to 1.54, marking an increase of 0.36.
• For Interest Coverage Ratio (X), as of Mar 20, the value is -33.49. This value is below the healthy minimum of 3. It has decreased from 4.63 (Mar 19) to -33.49, marking a decrease of 38.12.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is -46.61. This value is below the healthy minimum of 3. It has decreased from -19.51 (Mar 19) to -46.61, marking a decrease of 27.10.
• For Enterprise Value (Cr.), as of Mar 20, the value is 215.95. It has decreased from 1,435.09 (Mar 19) to 215.95, marking a decrease of 1,219.14.
• For EV / Net Operating Revenue (X), as of Mar 20, the value is 1.48. This value is within the healthy range. It has decreased from 9.30 (Mar 19) to 1.48, marking a decrease of 7.82.
• For EV / EBITDA (X), as of Mar 20, the value is -7.09. This value is below the healthy minimum of 5. It has decreased from 781.38 (Mar 19) to -7.09, marking a decrease of 788.47.
• For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 1.39. This value is within the healthy range. It has decreased from 4.51 (Mar 19) to 1.39, marking a decrease of 3.12.
• For Price / BV (X), as of Mar 20, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 2.62 (Mar 19) to 0.44, marking a decrease of 2.18.
• For Price / Net Operating Revenue (X), as of Mar 20, the value is 1.39. This value is within the healthy range. It has decreased from 4.51 (Mar 19) to 1.39, marking a decrease of 3.12.
• For EarningsYield, as of Mar 20, the value is 0.96. This value is below the healthy minimum of 5. It has increased from -0.17 (Mar 19) to 0.96, marking an increase of 1.13.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness